La Jolla Pharma Balance Sheet - Quarterly (NASDAQ:LJPC)

Add to My Stocks
$20.95 $0.69 (3.41%) LJPC stock closing price Sep 18, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at La Jolla Pharma balance sheet. As in our La Jolla Pharma stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Quarterly results are typically accompanied with the company releasing financial statements. The La Jolla Pharma balance sheet for 2018 Q2 shows total assets of $273.14M. The company has a asset turnover ratio of 0.03. Also see: La Jolla Pharma revenue and La Jolla Pharma operating cash flow for the same quarter.

View and download La Jolla Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets5.28M6.32M3.14M1.77M1.77M1.68M1.5M1.5M1.54M1.47M
Total Current Assets
Property Plant & Equipment--26.8M---4.22M---
Accumulated Depreciation--2.23M---1.08M---
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable----------
Accounts Payable6.07M7.32M11.48M6.23M5.92M4.17M6.65M1.99M2.25M2.4M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses11.57M7.32M5.69M4.02M2.35M1.5M3.1M5.23M2.9M2.76M
Income Taxes Payable----------
Other Current Liabilities1.37M1.37M1.37M-------
Total Current Liabilities
Deferred Taxes/Income138.46M13.47M12.78M-------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock6.64M6.64M6.64M6.64M6.64M6.64M6.64M6.64M6.64M6.64M
Common Stock Net----------
Capital Surplus933.84M922.8M803.07M796.11M790.35M785.64M661.1M657.46M653.53M650.19M
Retained Earnings-824.82M-772.04M-721.51M-682.96M-656.68M-629.95M-606.71M-581.82M-560.57M-545M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity115.67M157.41M88.2M119.79M140.31M162.33M61.03M82.28M99.61M111.83M
Total Liabilities & Shareholders Equity273.14M186.9M119.53M130.05M148.58M168M70.79M89.52M104.77M117M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest La Jolla Pharma stock price, and La Jolla Pharma historical stock prices show the stock price movement over time, and the La Jolla Pharma PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: Anything that the La Jolla Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. La Jolla Pharma had total assets of $273.14M.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for La Jolla Pharma is $157.47M. Shareholders equity comes under liabilities as it is money the company owes the holders of LJPC stock.

La Jolla Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio